HH BIOTECHNOLOGY HOLDINGS COMPANY (OTCMKTS:HHBT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
HH BIOTECHNOLOGY HOLDINGS COMPANY (OTCMKTS:HHBT) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On November 18, 2016, the Board of Directors of HH Biotechnology Holdings Company (the “Company”) adopted resolutions increasing the number of directors on the board to five and electing Mr. Charles T. Mathews as a director to fill the new directorship, and Mr. Mathews was assigned as the chairman of the Compensation Committees of the Board of Directors of the Company.
For service on the Board, Mr. Mathews will receive a quarterly fee of $10,000 and reimbursement of expenses.
About HH BIOTECHNOLOGY HOLDINGS COMPANY (OTCMKTS:HHBT)
HH Biotechnology Holdings Company, formerly Great China International Holdings, Inc., is engaged in commercial and residential real estate investment, development, sales and/or management in the city of Shenyang, Liaoning Province, in the People’s Republic of China (PRC). The Company’s business segments are Property for sale, and Rental income and Income of management fee of commercial buildings. The Company conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. It is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang. The Company’s leasing and management services are conducted primarily with respect to its real estate projects, which include President Building, Chenglong Garden and the Maryland Building. It also holds over 2,190 square meters of retail space in Qiyun New Village. HH BIOTECHNOLOGY HOLDINGS COMPANY (OTCMKTS:HHBT) Recent Trading Information
HH BIOTECHNOLOGY HOLDINGS COMPANY (OTCMKTS:HHBT) closed its last trading session 00.00 at 3.10 with 1,314 shares trading hands.
HH Biotechnology Holdings Company, formerly Great China International Holdings, Inc., is engaged in commercial and residential real estate investment, development, sales and/or management in the city of Shenyang, Liaoning Province, in the People’s Republic of China (PRC). The Company’s business segments are Property for sale, and Rental income and Income of management fee of commercial buildings. The Company conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. It is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang. The Company’s leasing and management services are conducted primarily with respect to its real estate projects, which include President Building, Chenglong Garden and the Maryland Building. It also holds over 2,190 square meters of retail space in Qiyun New Village. HH BIOTECHNOLOGY HOLDINGS COMPANY (OTCMKTS:HHBT) Recent Trading Information
HH BIOTECHNOLOGY HOLDINGS COMPANY (OTCMKTS:HHBT) closed its last trading session 00.00 at 3.10 with 1,314 shares trading hands.
